Biomarin Pharmaceutical Inc header image

Biomarin Pharmaceutical Inc

BMRN

Equity

ISIN null / Valor 729021

NASDAQ (2026-02-27)

USD 61.73+1.01%

Biomarin Pharmaceutical Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Biomarin Pharmaceutical Inc, founded in 1997, focuses on developing and commercializing therapies for rare genetic disorders. The company has successfully brought to market treatments for conditions such as achondroplasia, severe hemophilia A, and several inherited and lysosomal storage diseases. Utilizing a range of treatment approaches, Biomarin continues to expand its portfolio with a robust pipeline of investigational medicines currently undergoing clinical and preclinical trials. This strategic emphasis on specialized therapies aims to address significant unmet medical needs within the rare disease community.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-10.7%1Y

-40.2%3Y

-20.3%5Y

Performance

35.2%1Y

32.4%3Y

32.3%5Y

Volatility

11859 M

Market cap (USD)

2,180,013

Daily traded volume (Shares)

66.3 / 65.27

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

DXC Technology Company

DXC Technology Company Valor: 35991811

Annual Return

-50%0%+50%

Risk level

110

-0.40%USD 12.59

BioNTech SE

BioNTech SE Valor: 50030055

Annual Return

-50%0%+50%

Risk level

110

1.31%USD 110.23

MKS Instruments Inc

MKS Instruments Inc Valor: 616689

Annual Return

-50%0%+50%

Risk level

110

-0.09%USD 244.46

Nebius Group N.V.

Nebius Group N.V. Valor: 12955842

Annual Return

-50%0%+50%

Risk level

110

-13.05%USD 91.19

Rapid7 Inc

Rapid7 Inc Valor: 28570046

Annual Return

-50%0%+50%

Risk level

110

-2.66%USD 6.22

Progress Software Corp

Progress Software Corp Valor: 963966

Annual Return

-50%0%+50%

Risk level

110

-0.50%USD 41.88

BigCommerce Holdings Inc

BigCommerce Holdings Inc Valor: 56073608

Annual Return

-50%0%+50%

Risk level

110

-2.80%USD 2.78

GoDaddy Inc

GoDaddy Inc Valor: 24674951

Annual Return

-50%0%+50%

Risk level

110

1.11%USD 87.16

Editas Medicine Inc

Editas Medicine Inc Valor: 30992799

Annual Return

-50%0%+50%

Risk level

110

0.92%USD 2.20

Lightspeed Commerce Inc

Lightspeed Commerce Inc Valor: 112970662

Annual Return

-50%0%+50%

Risk level

110

-4.50%CAD 12.31

SIX

FactSet

Clearbit

Logos provided by Clearbit